Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LEVANT

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|January 1, 1992
Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studiesC B Nemeroff, B Levant, B Myers, et al.
Regulatory Peptides|February 1, 1991
Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugsB Levant, G Bissette, E Widerlöv, et al.
European Journal of Pharmacology|May 24, 1995
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptorsB Levant, D E Grigoriadis, E B De Souza
Brain Research|March 20, 1992
Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatmentB Myers, B Levant, G Bissette, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotrideB Levant, B Garimelli, R A Shafer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic studyG N Bancroft, K A Morgan, R J Flietstra, et al.
Brain Research. Molecular Brain Research|February 1, 1992
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatumB Levant, K M Merchant, D M Dorsa, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2008
The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptorsJ M Witkin, B Levant, A Zapata, et al.
Endocrinology|February 1, 1995
Apparent seasonal rhythms in hypothalamic neuropeptides in rats without photoperiod changesG Bissette, D Griff, M Carnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteinsT A Slotkin, B Levant, L Orband-Miller, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|January 1, 1992
Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studiesC B Nemeroff, B Levant, B Myers, et al.
Regulatory Peptides|February 1, 1991
Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugsB Levant, G Bissette, E Widerlöv, et al.
European Journal of Pharmacology|May 24, 1995
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptorsB Levant, D E Grigoriadis, E B De Souza
Brain Research|March 20, 1992
Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatmentB Myers, B Levant, G Bissette, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotrideB Levant, B Garimelli, R A Shafer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic studyG N Bancroft, K A Morgan, R J Flietstra, et al.
Brain Research. Molecular Brain Research|February 1, 1992
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatumB Levant, K M Merchant, D M Dorsa, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2008
The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptorsJ M Witkin, B Levant, A Zapata, et al.
Endocrinology|February 1, 1995
Apparent seasonal rhythms in hypothalamic neuropeptides in rats without photoperiod changesG Bissette, D Griff, M Carnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteinsT A Slotkin, B Levant, L Orband-Miller, et al.
Pageof 4